← Back to Search

Behavioural Intervention

VR Speech-Language Therapy for Speech Disorders

N/A

Recruiting

Led By Adriana Rios Rincon, PhD, R.OT

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Presence of a speech disorder

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 12 weeks

Awards & highlights

Study Summary

This trial aims to improve patient adherence to rehabilitation therapies by using virtual reality (VR) to make them more fun/engaging. It hopes to improve outcomes and satisfaction with vocal therapy.

Who is the study for?

This trial is for English-speaking adults with a speech disorder who are currently receiving speech-language therapy at the Glenrose Rehabilitation Hospital. They must be able to consent to participate. It's not for those with substance use disorders, comprehension issues due to communication disorders, severe cognitive or behavioral impairments, or a history of neurological or psychiatric conditions.Check my eligibility

What is being tested?

The study tests the effectiveness of Virtual Reality (VR) GlenXRose Speech-Language Therapies in improving patient adherence and treatment outcomes compared to traditional methods. It aims to make rehabilitation engaging through gamification and assesses feasibility, clinician feedback, costs, and clinical results.See study design

What are the potential side effects?

While specific side effects are not detailed for VR therapies, potential discomforts may include motion sickness from VR use, eye strain or fatigue from prolonged screen time. These experiences can vary among individuals.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have a speech disorder.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Acoustic Analysis of Voice

Change in Compliance Rate

Change in Frequency and Treatment Adherence Rates

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Virtual Reality Delivered Therapy + Standard Clinical CareExperimental Treatment1 Intervention

The GlenXRose virtual reality therapies will be delivered to participants using a head-mounted device to allow vocal therapy and practice. Participants will also receive routine clinical care provided by speech-language pathologists.

Group II: Standard Clinical CareActive Control1 Intervention

Participants will receive routine clinical care provided by speech-language pathologists.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor

889 Previous Clinical Trials

385,147 Total Patients Enrolled

Alberta Health servicesOTHER

158 Previous Clinical Trials

649,636 Total Patients Enrolled

Antonio Miguel Cruz, DrScStudy ChairUniversity of Alberta

Media Library

GlenXRose Virtual Reality Speech Therapies (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05695131 — N/A

Vocal Cord Dysfunction Research Study Groups: Virtual Reality Delivered Therapy + Standard Clinical Care, Standard Clinical Care

Vocal Cord Dysfunction Clinical Trial 2023: GlenXRose Virtual Reality Speech Therapies Highlights & Side Effects. Trial Name: NCT05695131 — N/A

GlenXRose Virtual Reality Speech Therapies (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05695131 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is participation in this trial still viable for potential participants?

"According to the information available on clinicaltrials.gov, no new patients are currently being recruited for this trial which was initially posted on April 1st 2023 and last updated January 14th of the same year. Nevertheless, there are 8 different medical studies that presently require enrolment at this time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Clinical Feasibility & Validation of the Virtual Reality GlenxRose Speech-Language Therapies

2023. "Clinical Feasibility & Validation of the Virtual Reality GlenxRose Speech-Language Therapies". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05695131.